EUVIMEDEUVIMED entdecken
Crossref

Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study

Biagio Maria Sancetta, Lorenzo Ricci, Jacopo Lanzone, Marilisa Boscarino, Flavia Narducci, Giulia Lippa, Marianna Nesta, Vincenzo Di Lazzaro, Mario Tombini, Giovanni Assenza

Neurological Sciences · 2024

DOI: 10.1007/s10072-024-07354-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2024. Verfasst von Biagio Maria Sancetta und 9 weiteren Autor:innen. Beteiligte Einrichtung: UOC Neurologia, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Rome, Italy. biagio.sancetta@unicampus.i…. Hauptthemen laut MEDLINE: Carbamazepine, Anticonvulsants, Dibenzazepines, Epilepsy. Die Arbeit nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Carbamazepine (CBZ) is a first-choice anti-seizure medication (ASM) whose efficacy is often invalidated by adverse effects (AEs). Eslicarbazepine (ESL) is a structural derivative of CBZ with better pharmacokinetic/tolerability profiles. We describe our experience of the overnight CBZ to ESL switch in people with epilepsy (PwE) to improve seizure control, AEs, and ASMs adherence. METHODS: We retrospectively included 19 PwE (12 females, 53 ± 21 years old) who underwent CBZ to ESL overnight switch due to single/multiple issues: poor efficacy (pEff, N = 8, 42%), tolerability (pToll, N = 11, 58%), adherence (pAdh, N = 2, 10%). 9/19 (47%) had psychiatric comorbidities. Clinical variables, seizure frequency, and AEs were recorded at switch time (T0) after 3.5 ± 3 (T1) and 6.5 ± 1.5 months (T2). RESULTS: At T1, in pEff group, 1/8 (13%) was seizure free, 2/8 (25%) were responders (> 50% seizure reduction), 2/8 (25%) had no seizure changes, 3/8 (37%) had seizure worsening; the latter were those with the most severe epilepsy and encephalopathy. In pToll group, all PwE experienced AEs disappearance/amelioration. In pAdh group, all PwE reported adherence amelioration. Four dropouts. At T2, no changes were recorded within groups, while in the whole sample, 6/15 (40%) were responders, and 4/15 (27%) were seizure-free. No one complained of Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation psychiatric worsening, while 6/19 (32%) experienced mood/behavior benefits. CONCLUSIONS: CBZ to ESL overnight switch offers an opportunity to improve efficacy, tolerability, adherence, and psychiatric symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbamazepineAnticonvulsantsDibenzazepinesEpilepsyHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedDrug SubstitutionMedication AdherenceTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

EpilepsyEslicarbazepine acetateOvernight switch

Substanzen

CarbamazepineAnticonvulsantsDibenzazepineseslicarbazepine

Autor:innen und Institutionen

  • UOC Neurologia, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Rome, Italy. biagio.sancetta@unicampus.it.
  • Research Unit of Neurology, Neurophysiology and Neurobiology, Department of Medicine and Surgery, Università Campus Bio-Medico Di Roma, Via Alvaro del Portillo, 21, 00128, Rome, Italy. biagio.sancetta@unicampus.it.
  • UOC Neurologia, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Rome, Italy.
  • Research Unit of Neurology, Neurophysiology and Neurobiology, Department of Medicine and Surgery, Università Campus Bio-Medico Di Roma, Via Alvaro del Portillo, 21, 00128, Rome, Italy.
  • Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department of the Milano Institute, Milan, Italy.

Zitieren

APA

Sancetta, B. M., Ricci, L., Lanzone, J., Boscarino, M., Narducci, F., Lippa, G., Nesta, M., Di Lazzaro, V., Tombini, M., & Assenza, G. (2024). Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study. Neurological Sciences. https://doi.org/10.1007/s10072-024-07354-6

Vancouver

Sancetta BM, Ricci L, Lanzone J, Boscarino M, Narducci F, Lippa G, et al. Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study. Neurological Sciences. 2024. doi:10.1007/s10072-024-07354-6

BibTeX
@article{Sancetta2024,
  author = {Sancetta, Biagio Maria and Ricci, Lorenzo and Lanzone, Jacopo and Boscarino, Marilisa and Narducci, Flavia and Lippa, Giulia and Nesta, Marianna and Di Lazzaro, Vincenzo and Tombini, Mario and Assenza, Giovanni},
  title = {Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study},
  journal = {Neurological Sciences},
  year = {2024},
  doi = {10.1007/s10072-024-07354-6}
}
Kostenlos starten →